Maximising Impact: Professor Sir Tony Kouzarides’ Lessons from a Career in Research and Start-ups
​Join us for an inspiring talk with Prof Sir Tony Kouzarides, a world-renowned cancer and epigenetics researcher, and founder of several pioneering organisations:

​Abcam – antibody company (acq. $5.6B)

​Storm Therapeutics – clinical-stage first-in-class drug discovery company

​Chroma Therapeutics – drug discovery vehicles

​Milner Therapeutics Institute – bridging academia, start-ups, biotechs, and pharma

​Vellos – venture builder founded to support UK scientists to build world-changing companies

​Sir Tony will share personal lessons on ‘Maximising Impact’, drawing on his career at the intersection of science, entrepreneurship, and translational success.

​This event is co-hosted by Fifty Years, an early-stage VC firm. At 50Y, the team have built deep tech companies themselves and published the Spinout Playbook, the ultimate guide to spin out of academia. Fifty Years have backed over 100 deep tech startups and helped them raise over $4.6B.

​Everything the the 50Y team knows about deep tech entrepreneurship has been distilled into 5050, a free, 16-week programme to help great scientists and engineers become great founders. Register your interest for the next cohort, kicking off in September 2025.

​Powered by the Advanced Research and Invention Agency (ARIA). Find our privacy policy here www.fiftyyears.com/privacy
Date: 13 June 2025, 12:00
Venue: Medical Sciences Teaching Centre, off South Parks Road OX1 3PL
Venue Details: Goss Lecture Theatre
Speaker: Professor Sir Tony Kouzarides (Co-founder of the Milner Therapeutics Institute | University of Cambridge)
Organiser contact email address: milan.sobota@stx.ox.ac.uk
Booking required?: Required
Booking url: https://lu.ma/75oc3av1
Audience: Members of the University only
Editor: Clea Boorman